From July 1, 2022 to September 23, 2022, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 93,781 shares, representing 0.82% for KRW 989.14 million under the buyback announced on March 27, 2020.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,520 KRW | +0.67% | -0.27% | -20.09% |
1st Jan change | Capi. | |
---|---|---|
-20.09% | 61.8M | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- A001540 Stock
- News Ahn-Gook Pharmaceutical Co., Ltd.
- Tranche Update on Ahn-Gook Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on March 27, 2020.